EXHIBIT 10.55 CONSULTING AGREEMENT THIS CONSULTING AGREEMENT (the "Agreement") is made as of October 5, 2001 (the "Effective Date") by and between ARIAD Pharmaceuticals, Inc., a Delaware corporation (the "Company"), and Brian A. Lajoie (the...Consulting Agreement • March 22nd, 2002 • Ariad Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Massachusetts
EXECUTION COPYLoan and Security Agreement • March 22nd, 2002 • Ariad Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Massachusetts
EXHIBIT 10.56 2002 EXECUTIVE EMPLOYMENT AGREEMENT 2002 EMPLOYMENT AGREEMENT (the "Agreement") made as of March 4, 2002 by and between ARIAD Pharmaceuticals, Inc. (the "Company") a Delaware corporation, and Laurie A. Allen, Esq. (the "Employee"). 1....Employment Agreement • March 22nd, 2002 • Ariad Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Massachusetts
EXHIBIT 10.51 FINANCIAL COVENANTS ADDENDUM NO. 001 TO MASTER LEASE AGREEMENT DATED AS OF DECEMBER 27, 2001 THIS ADDENDUM (this "Addendum") amends and supplements the above referenced agreement (the "Agreement"), between General Electric Capital...Master Lease Agreement • March 22nd, 2002 • Ariad Pharmaceuticals Inc • Biological products, (no disgnostic substances)
EXHIBIT 10.53 REVISED AND RESTATED RESEARCH AND DEVELOPMENT AGREEMENT This Revised and Restated Research and Development Agreement (the "Agreement"), dated as of March 15, 2002 ("Execution Date"), between ARIAD Pharmaceuticals, Inc., a Delaware...Research and Development Agreement • March 22nd, 2002 • Ariad Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Massachusetts
EXHIBIT 10.50 MASTER SECURITY AGREEMENT dated as of December 27, 2001 ("Agreement") THIS AGREEMENT is between General Electric Capital Corporation (together with its successors and assigns, if any, "Secured Party") and Ariad Pharmaceuticals, Inc....Master Security Agreement • March 22nd, 2002 • Ariad Pharmaceuticals Inc • Biological products, (no disgnostic substances)
EXHIBIT 10.57 ARIAD GENE THERAPEUTICS, INC. STOCK TRANSFER AGREEMENT In consideration of the covenants and agreements set forth herein and for other good and valuable consideration, the receipt and sufficiency of which are hereby mutually...Stock Transfer Agreement • March 22nd, 2002 • Ariad Pharmaceuticals Inc • Biological products, (no disgnostic substances)
In consideration of the covenants and agreements set forth herein and for other good and valuable consideration, the receipt and sufficiency of which are hereby mutually acknowledged, the parties hereto covenant and agree as follows:
